Non-DLBCL monomorphic and Hodgkin lymphoma PTLD: clinical insights and treatment strategies [PDF]
Blood Advances: Monomorphic posttransplant lymphoproliferative disorders (PTLDs) beyond diffuse large B-cell lymphoma (DLBCL) are rare, biologically heterogeneous entities with limited prospective data to guide treatment.
Suheil Albert Atallah-Yunes +2 more
doaj +2 more sources
A comparison of genome-wide association analyses of persistent symptoms after Lyme disease, fibromyalgia, and myalgic encephalomyelitis – chronic fatigue syndrome [PDF]
BMC Infectious DiseasesBackground Up to 20% of Lyme disease cases experience post-treatment Lyme disease syndrome (PTLDS). The biological basis for PTLDS is poorly understood and no evidence-based treatment has been identified.
Annemarie G. Hirsch +7 more
doaj +2 more sources
HLA and pathogens in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and other post-infection conditions [PDF]
Scientific ReportsViral infections have been widely implicated in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) pathogenesis. Recent evidence has also identified certain Human Leukocyte Antigen (HLA) alleles that are significantly associated with ME/CFS risk/
Apostolos P. Georgopoulos +2 more
doaj +2 more sources
Pre-existing oncohematological disease in kidney transplant recipients: impact on graft survival, acute rejection, and long-term clinical outcomes [PDF]
Frontiers in ImmunologyIntroductionOncohematological disorders are heterogeneous conditions that present significant challenges in management prior to transplantation. Data about rejection risk, disease recurrence, eligibility criteria, and requested remission time before ...
Alberto Mella +32 more
doaj +2 more sources
Current and emerging approaches for eliminating Borrelia burgdorferi and alleviating persistent Lyme disease symptoms [PDF]
Frontiers in MicrobiologyLyme disease is the most prevalent tick-borne infection caused by Borrelia burgdorferi bacteria in North America. Other Borrelia species are predominately the cause of this disease in Eurasia with some distinct and various overlapping manifestations ...
Kashaf Zafar +2 more
doaj +2 more sources
Delving deeper into the pathogenesis and genomics of posttransplant diffuse large B‐cell lymphoma [PDF]
HemaSpherePosttransplant lymphoproliferative disorders (PTLDs) are a well‐known complication of solid organ transplantation and allogeneic hematopoietic stem cell transplantation.
Flore Sneyers +3 more
doaj +2 more sources
Myositis Autoantibodies in Patients with Suspected Post-Treatment Lyme Disease Syndrome
Life, 2023 Most patients suffering from Lyme disease are effectively treated with antibiotics. In some patients, however, problems persist for a long time despite appropriate therapy.
Kristyna Sloupenska +10 more
doaj +1 more source
BMC Infectious Diseases, 2022 Background Patients with Lyme borreliosis (LB) may report persisting non-specific symptoms such as fatigue, widespread musculoskeletal pain or cognitive difficulties.
Laurence Geebelen +12 more
doaj +1 more source
PLoS ONE, 2021 BackgroundPersistent symptoms attributed to presumed tick-bite exposure constitute an unresolved medical controversy. We evaluated whether Swedish adults who met the criteria for post-treatment Lyme disease syndrome (PTLDS) exhibited characteristics ...
Kenneth Nilsson +8 more
doaj +1 more source
A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients
mBio, 2020 Lyme disease is the most common vector-borne disease in the United States, with an estimated incidence of 300,000 infections annually. Antibiotic intervention cures Lyme disease in the majority of cases; however, 10 to 20% of patients develop ...
Madeleine Morrissette +10 more
doaj +1 more source